An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
出版年份 2021 全文链接
标题
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
作者
关键词
Liver Diseases, Metabolic Associated Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Prevalence, Risk Factors
出版物
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-12-04
DOI
10.1016/j.cgh.2021.11.038
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
- (2021) Shang-Chin Huang et al. Gut and Liver
- Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
- (2021) Gabriel Tayguara Silveira Guerreiro et al. Hepatology International
- Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population
- (2021) Stefano Ciardullo et al. LIVER INTERNATIONAL
- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
- (2021) Madunil Anuk Niriella et al. PLoS One
- Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study
- (2021) Yu-ling Chen et al. BMC GASTROENTEROLOGY
- Metabolic dysfunction-associated fatty liver disease (MAFLD) – rather a bystander than a driver of mortality
- (2021) Georg Semmler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
- (2021) Hao-Jie Zhang et al. CHINESE MEDICAL JOURNAL
- MAFLD vs NAFLD: Where are we?
- (2021) Alessandro Mantovani DIGESTIVE AND LIVER DISEASE
- MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
- (2021) Tsubasa Tsutsumi et al. HEPATOLOGY RESEARCH
- Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study
- (2021) Shuhei Fukunaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China
- (2021) Yebei Liang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
- (2021) Shanshan Liu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population
- (2021) Jiahua Fan et al. Nutrition & Metabolism
- The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases
- (2021) Hideki Fujii et al. Scientific Reports
- MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
- (2021) Jiaofeng Huang et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Burden of Disease due to Nonalcoholic Fatty Liver Disease
- (2020) Mark D. Muthiah et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- From NAFLD to MAFLD: when pathophysiology succeeds
- (2020) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China
- (2020) Hongbin Li et al. International Journal of Environmental Research and Public Health
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Associations Between Reproductive and Hormone-related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population
- (2020) Jun Wang et al. Clinical Gastroenterology and Hepatology
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
- (2020) Amélio F. Godoy-Matos et al. Diabetology & Metabolic Syndrome
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Non-alcoholic fatty liver disease: Not time for an obituary just yet!
- (2020) Shivaram Prasad Singh et al. JOURNAL OF HEPATOLOGY
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
- (2020) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Seriously misleading results using inverse of Freeman‐Tukey double arcsine transformation in meta‐analysis of single proportions
- (2019) Guido Schwarzer et al. Research Synthesis Methods
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
- (2018) Mazen Noureddin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
- (2018) Laura Pimpin et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults
- (2017) Sean Chun-Chang Chen et al. Scientific Reports
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Alcoholic liver disease: mechanisms of injury and targeted treatment
- (2015) Alexandre Louvet et al. Nature Reviews Gastroenterology & Hepatology
- What is publication bias in a meta-analysis?
- (2015) Philip Sedgwick BMJ-British Medical Journal
- What is publication bias in a meta-analysis?
- (2015) Philip Sedgwick BMJ-British Medical Journal
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
- (2012) Zobair M. Younossi et al. MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now